Robuta

https://malkari.in/indian-stock-market-review-q2-earnings-of-torrent-pharma-apollo-hospitals-and-more/ Indian Stock Market Review: Q2 Earnings of Torrent Pharma, Apollo Hospitals, and More -... Nov 12, 2025 - The Indian stock market has been witnessing significant fluctuations in recent times, largely driven by the Q2 earnings of top companies. In this article, we indian stock markettorrent pharmaapollo hospitalsand morereview https://scanx.trade/stock-market-news/earnings/torrent-pharma-reports-20-net-profit-growth-in-q1-driven-by-strong-performance-across-key-markets/15245001 Torrent Pharma Reports 20% Net Profit Growth in Q1, Driven by Strong Performance Across Key Markets Torrent Pharmaceuticals announced robust Q1 financial results with revenue from operations increasing by 11% to Rs. 3,178.00 crores. Operating EBITDA grew by... torrent pharmanet profitkey marketsreportsgrowth https://groww.in/options/torrent-pharmaceuticals-ltd/TORNTPHARM26SEP4400PE Torrent Pharma Options - Live Nifty/NSE Option Price Chart | Groww torrent pharmaoption priceoptionslivenifty https://manufacturing.economictimes.indiatimes.com/news/life-sciences/zydus-torrent-pharma-join-hands-to-co-market-semaglutide-injection/129655710 Zydus, Torrent Pharma join hands to co-market Semaglutide injection, ETManufacturing As part of the agreement, Torrent Pharma will pay an upfront licensing fee to Zydus. torrent pharmajoin handszydusmarketsemaglutide https://investyadnya.in/stock-articles/6-point-analysis-of-torrent-pharma-stable-growth-in-all-geographies-with-inflation-in-expenses-led-to-bottom-line-pressures-for-torrent-pharma-in-q-2-fy-2022 6 Point Analysis of Torrent Pharma | Stable growth in all geographies with inflation in expenses... torrent pharmain allpointanalysisstable https://www.outlookbusiness.com/companies/indias-torrent-pharma-in-advanced-talks-with-cvc-bain-capital-to-fund-cipla-deal-report Advanced talks for Torrent Pharma to buyout Cipla with CVC Capital Partners and Bain Capital –... Sep 18, 2023 - Torrent Pharmaceuticals is in advanced discussions with CVC Capital Partners and Bain Capital to fund a buyout of Cipla's promoter stake according to a Reuters... cvc capital partnerstorrent pharmaadvancedtalksbuyout